In morning trading session on Monday, shares are decreasing 0.69% to $78.67.
The action comes after the company last week closed its popular Health Sciences Fund to new investors, according to Barron's. The decision to close the fund was made to maintain the integrity of the fund's investment strategy and to protect the interests of existing shareholders, the company stated.
T. Rowe Price Group is a financial services holding company headquartered in Baltimore.
About 310,000 shares of T. Rowe Price were traded by 11:05 am today, below the company's trading volume of about 1,356,000 shares a day.
Separately, TheStreet Ratings team rates PRICE (T. ROWE) GROUP as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate PRICE (T. ROWE) GROUP (TROW) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself."
Highlights from the analysis by TheStreet Ratings Team goes as follows: